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Abstract 22 
Polyphenol consumption has become a popular method of trying to temper muscle damage. 23 
Cocoa flavanols (CF) have attracted attention due to their high polyphenol content and 24 
palatability. As such, this study will investigate whether an acute dose of CF can aid recovery 25 
following exercise induced muscle damage (EIMD). The study was a laboratory-based, 26 
randomised, single-blind, nutrient-controlled trial involving 23 participants (13 females, 10 27 
males). Participants were randomised into either control ~0mg CF (CON, n=8, 4 females), high 28 
dose of 830mg CF (CF830, n=8, 5 females) or supra dose of 1245mg CF (CF1245, n=7, 4 29 
females). The EIMD protocol consisted of five sets of 10 maximal concentric/eccentric 30 
hamstring curls and immediately consumed their assigned drink following completion. To 31 
measure muscle recovery, maximal voluntary isometric contraction (MVIC) of the knee flexors 32 
at 60° and 30°, a visual analogue scale (VAS) and lower extremity function scale (LEFS) were 33 
taken at baseline, immediately, 24, 48 and 72-hr post-EIMD. There was a main effect for time 34 
for all variables (P<0.05). However, no significant differences were observed between groups 35 
for all measures (P>0.17). At 48 hr there were large effect sizes between CON and CF1245 for 36 
MVIC60 (P=0.17, d=0.8), MVIC30 (P=0.26, d=0.8), MVIC30 percentage change (P=0.24 37 
d=0.9) and VAS (P=0.25, d=0.9). As no significant differences were observed following the 38 
consumption of CF there is reason to believe that CF offer no benefit for muscle recovery when 39 
ingested acutely.  40 
 41 
 42 
 43 
 44 
 45 
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1. Introduction 46 
Eccentric muscle contractions are typically responsible for the muscular disruption that leads 47 
to exercise induced muscle damage (EIMD) (Nikolaidis et al., 2007). Therefore, resistance 48 
training and intermittent high-intensity exercise often evoke EIMD (Owens, Twist, Cobley, 49 
Howatson, & Close, 2019). Consequences of EIMD include inflammation and oxidative stress 50 
(Kanda et al., 2013), impaired force generating capacity (Twist & Eston, 2009), and increased 51 
muscle soreness (Impellizzeri et al., 2008). Optimising the time course of recovery is now a 52 
priority in modern sport, mainly due to the rapid turnaround of competitions and fixtures. 53 
Contemporary examples include tennis players performing every other day at major 54 
championships and congested fixture periods in soccer when players perform two 90 min 55 
matches within three days. Notably, injury-risk and muscular fatigue may be increased during 56 
congested fixture periods in soccer, namely due to the insufficient recovery time between 57 
matches (Ekstrand, Hägglund, & Waldén, 2011; Page, Marrin, Brogden, Greig, & Research, 58 
2019). Therefore, the aim of recovery is to restore normative values for an individual following 59 
exercise by reducing neuromuscular fatigue, soreness and restoring contractile functional 60 
capacity. To reduce fatigue and facilitate recovery, high carbohydrate protein meals or 61 
beverages, as well as high polyphenolic foodstuffs (e.g., cocoa) have become a common feature 62 
of an athlete’s diet (Knapik et al., 2016). Polyphenol is an umbrella term for the different 63 
classes of plant metabolites, including flavonoids, stilbenes, phenolic acids and lignans. 64 
Flavonoids are the largest group of dietary polyphenols and the most common source of 65 
antioxidants within the diet (Scalbert, Johnson, & Saltmarsh, 2005). In recent years, a subclass 66 
of flavonoids, known as flavanols, such as catechin and epicatechin, have attracted much 67 
attention as health promoting nutrients. Sources of flavanols include lychees, apples, teas, 68 
broad beans and cocoa (Williamson, 2017). Cocoa has the highest proportion of flavanols per 69 
serving than any other natural source (Lee, Kim, Lee, & Lee, 2003). Previous research has 70 
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focused on the effects of cocoa flavanols (CF) on the cardiovascular system, with evidence 71 
suggesting CF intake can reduce endothelial dysfunction by improving flow mediated dilation 72 
(Hooper et al., 2012) and reducing blood pressure (Buitrago-Lopez et al., 2011). Furthermore, 73 
CF have been shown to enhance endogenous antioxidant capacity (Serafini & Peluso, 2016), 74 
limit oxidative stress (Allgrove et al., 2011), and influence the inflammatory process by 75 
reducing both platelet aggregation and the stimulation of neutrophils (Ellinger & Stehle, 2016).  76 
Regarding muscle recovery and exercise, research has shown that acute (single dose on day of 77 
exercise stimulus) and sub-chronic (regular intake for ≥14 days) CF supplementation of ≥200 78 
mg reduces exercise-induced oxidative stress (Allgrove et al., 2011; Davison, Callister, 79 
Williamson, Cooper, & Gleeson, 2012). Furthermore, in relation to exercise, the ingestion of 80 
CF may improve sprint performance by potentially preventing ROS-increased calcium 81 
sensitivity of myofilaments within working muscles, therefore, delaying fatigue (de Carvalho 82 
et al., 2019; Patel, Brouner, & Spendiff, 2015). However, evidence is lacking regarding the 83 
impact of CF on markers of muscle recovery, such as perturbations in muscle function and an 84 
increase of perceived soreness. One such study used a CF dose too low (74 mg CF and 8 mg 85 
epicatechin) to be effective (Morgan, Wollman, Jackman, & Bowtell, 2018). Benefits begin to 86 
be observed at doses of ~700 mg CF; and more importantly, with >50 mg epicatechin, the most 87 
biologically active flavanol (Schroeter et al., 2006). However, an optimal dose is not yet known 88 
in addition to any potential dose response. Furthermore, previous research that investigated the 89 
impact of CF on muscle recovery did not induce notable muscle damage using a drop jumps 90 
protocol (de Carvalho et al., 2019) and a downhill running protocol (Peschek, Pritchett, 91 
Bergman, & Pritchett, 2013). This can be defined as reductions in muscle force-generating 92 
capability of ≥20% following EIMD (Paulsen, Ramer Mikkelsen, Raastad, & Peake, 2012). 93 
Therefore, making conclusions about the impact of CF on markers of muscle damage is 94 
difficult, indicating that more research is warranted. Furthermore, none of the previous studies 95 
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involved female participants, likely due to the purported protective effects of oestrogen against 96 
muscle damage (Tiidus, 2003) and physiological variations across the menstrual cycle 97 
(Hayashida, Shimura, Sugama, Kanda, & Suzuki, 2016). Therefore, investigating the effect of 98 
CF supplementation on muscle recovery in females is required. 99 
Therefore, the aims of this study were twofold; i) to investigate the impact of an acute dose of 100 
CF on indices of muscle recovery ii) to compare two different doses of CF on indices of muscle 101 
recovery. The hypothesis for this study was that EIMD might be attenuated following acute 102 
consumption of CF, with the highest dose offering the most benefit. 103 
2. Methods 104 
2.1 Participants 105 
Following institutional ethical approval and in agreement with the Declaration of Helsinki, 30 106 
participants consented to take part between the months of April 2019 to October 2019; 107 
however, only 23 completed the study (13 females, 10 males) due to the following reasons; 108 
two due to injury and five due to unforeseen circumstances following baseline testing. An a 109 
priori power calculation determined that a sample size of 21 was required for 80% power and 110 
to detect significance, based on the effect size from previous research regarding MVIC 111 
recovery at 48 hr (Bowtell, Sumners, Dyer, Fox, & Mileva, 2011). Baseline testing involved 112 
maximal voluntary isometric contractions (MVIC) of the knee flexors to assess muscle function 113 
and measures of perceived muscle soreness using a visual analogue scale (VAS) and lower 114 
extremity function scale (LEFS). All participants were classed as recreationally active and 115 
injury free for the previous six-months (both informed via self-report) and were not taking any 116 
dietary supplements (e.g., vitamin C, glutamine, or branched-chain amino acids). Participants 117 
were asked to avoid anti-inflammatory medications and resistance training during 118 
participation. A menstrual cycle questionnaire (Brown, 2017) was completed by the female 119 
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participants involved to reliably estimate cycle phase. The luteal phase was selected for testing 120 
or an equivalent period for participants who were on hormonal contraception, as to avoid peak 121 
oestrogen concentrations observed during the follicular phase (Brown, 2017). Participants 122 
completed each day within 26±2 hr of original participation to account for diurnal influence. 123 
2.2 Study Design 124 
The study was a laboratory-based, randomised, single-blind, nutrient-controlled trial. 125 
Participants were randomised into a control (CON), high (CF830) or supra (CF1245) group and 126 
remained unaware of their allocation for the entirety of the study. Participants were required to 127 
come to the laboratory for five days, the first being baseline testing and familiarisation of the 128 
EIMD protocol (ten sub-maximal concentric-eccentric hamstring curls). The remaining four 129 
days took place consecutively; as such, measures were taken in the following order: baseline, 130 
immediately post-EIMD (0 hr), 24, 48 and 72 hr post-EIMD. For randomisation, participants 131 
were assigned to separate strata, ‘strong’ and ‘not strong’, based on their baseline MVIC values 132 
and randomised into matched and counterbalanced groups (using random.org). To decide what 133 
could be classified as strong or not, a normative MVIC strength index was used [Risberg et al. 134 
(2018) for females and Ruas, Minozzo, Pinto, Brown, and Pinto (2015) for males]. Following 135 
this, eight participants were allocated to the control group (four females, four males), eight to 136 
the CF830 group (five females, three males), and seven to the CF1245 group (four females, three 137 
males).  138 
***INSERT TABLE 1 NEAR HERE*** 139 
2.3 Muscle Function 140 
Values were recorded for knee flexor MVIC using the isokinetic dynamometer (Cybex 141 
NORM®, Model 770, CA, USA), providing a reliable quantification of decrements in muscle 142 
function for assessing EIMD (Warren, Lowe, & Armstrong, 1999). Knee angles of 60° 143 
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(MVIC60) and 30° (MVIC30) of the anatomical zero (full knee flexion) were selected due to 144 
the differences in muscle activation at various knee angles; biceps femoris has increased 145 
activation at reduced angles, whilst semitendinosus and semimembranosus at greater knee 146 
angles (Onishi et al., 2002).  147 
2.4 Subjective Soreness 148 
Soreness was recorded using a 200 mm VAS, which has been previously included as a 149 
validated measure of subjective soreness (Peschek, Pritchett, Bergman, & Pritchett, 2013). The 150 
LEFS is a validated questionnaire which quantifies an individuals perceived level of muscle 151 
function using 20 hypothetical activities that are scored from 0 to 4; 0 = extreme difficulty; 4 152 
= no difficulty (de Carvalho et al., 2019).  153 
2.5 Muscle Damaging Protocol 154 
The exercise protocol used to induce muscle damage was adapted from White et al. (2008) 155 
using the Cybex Norm Isokinetic Dynamometer (CSMi, Boston, Massachusetts). Participants 156 
were then secured into the dynamometer at 85° hip flexion using straps to isolate the knee and 157 
remove hip flexor involvement. Body position was noted during baseline testing and replicated 158 
throughout. A specific warm-up consisting of 10 concentric/eccentric contractions of the knee 159 
flexors at a self-perceived low effort level was performed pre-exercise. Following the warm-160 
up, participants performed five sets of 10 maximal concentric/eccentric contractions of the knee 161 
flexors with an interset rest of one minute; rotation speed was 60°·s-1. Participants were verbally 162 
encouraged throughout and once all repetitions were completed, the participant immediately 163 
repeated the protocol on the opposite leg.  164 
2.6 Nutritional Intervention 165 
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Participants were blinded to which group they were assigned, with only the lead researcher 166 
being aware of the contents of each drink. Participants consumed their assigned beverage 167 
within five minutes following the protocol. Each beverage consisted of 300 ml water, 60 g 168 
maltodextrin and 25 g whey protein powder (20 g protein). The cocoa powder used was a 169 
commercially available high flavanol powder (Chococru© Extraordinary Flavanol Cocoa), 170 
containing ~8.3% flavanols and a total polyphenol content of ~12% (unpublished data from 171 
Chococru©). The beverage for CF830 included an additional 10 g of Chococru© cocoa powder 172 
which contained 830 mg CF (98.6 mg epicatechin) and for CF1245 15 g of Chococru© cocoa 173 
powder was added, containing 1245 mg CF (149.4 mg epicatechin; Table 2).  174 
***INSERT TABLE 2 NEAR HERE*** 175 
2.7 Dietary Measures 176 
Participants completed a 24-hour dietary recall each day of testing, totalling five food recalls, 177 
and were asked to continue eating their usual diet throughout testing. During baseline testing, 178 
participants were provided a list of high polyphenolic food and drink (cherries, blueberries, 179 
dark chocolate, green and black tea, wine, apples, lychees, pomegranates and fruit juices) to 180 
refrain from consuming three days before and during the testing period, reducing the 181 
confounding influence of other dietary polyphenols on recovery (Scalbert et al., 2005). Dietary 182 
analysis was carried out using Nutrimen (Dark Green Media Ltd, ©2016). 183 
2.8 Statistical analyses 184 
Statistical analysis was performed using IBM SPSS Statistics (version 24, IBM Corp., Armonk, 185 
N.Y., USA). All data was assessed for normality, a Greenhouse-Geisser correction was used if 186 
sphericity was violated. A repeated-measures analysis of variance was used to determine 187 
interaction and time effects for the recovery variables. If any significance was observed, Fisher 188 
LSD post hoc testing was performed to identify the point of significance. Data for MVIC60 189 
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and MVIC30 was calculated as percentage change from baseline alongside absolute means. To 190 
calculate effect sizes, Cohen’s d (d) was utilised, with the magnitude of effects considered 191 
small (0.2), moderate (0.5) and large (0.8). Significance was set at P≤0.05 pre-analysis. 192 
Descriptive statistics are reported as means (%) ± standard deviation (SD).  193 
 194 
 195 
 196 
 197 
***INSERT FIGURE 1 NEAR HERE*** 198 
 199 
 200 
 201 
 202 
3. Results 203 
There were no significant differences for participant characteristics or dietary intake between 204 
groups (P≥0.33). See Table 3 for dietary intake. 205 
***INSERT TABLE 3 NEAR HERE*** 206 
 207 
3.1 Muscle function 208 
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Muscle function measured using MVIC at 60° and 30° found a main effect of time (P<0.05). 209 
There were no significant differences between groups for knee flexor peak torque at MVIC60 210 
(P=0.99) or MVIC30 (P=0.95) at baseline. Following the exercise protocol, overall mean knee 211 
flexor peak torque reduced to 79% of baseline. There was a significant effect of time across all 212 
groups (P<0.05). For MVIC60 there were no significant differences between groups (P≥0.17). 213 
For MVIC30 there were no significant differences between groups (P≥0.55).  214 
3.2 Measures of Perceived soreness  215 
Perceived soreness measured using a VAS and LEFS found a main effect of time for both 216 
measures (P=<0.05). There were no significant differences between groups for VAS scores 217 
(P≥0.39). There were no significant differences between groups for LEFS scores (P≥0.75). 218 
***INSERT FIGURE 2 NEAR HERE*** 219 
***INSERT TABLE 4 NEAR HERE*** 220 
***INSERT TABLE 5 NEAR HERE*** 221 
 222 
4. Discussion 223 
The main aim of this study was to investigate whether various doses of CF have any impact on 224 
indices of muscle recovery following EIMD. Based on the results of the current research, no 225 
significant differences were found following the addition of CF. This study corroborates 226 
previous findings that suggest an acute dose of CF has no significant impact on measures of 227 
muscle function, or measures of perceived soreness (de Carvalho et al., 2019; Morgan et al., 228 
2018; Peschek et al., 2013). 229 
Differences between this study and previous studies should be noted, in that both de Carvalho 230 
et al. (2019) and Peschek et al. (2013) used EIMD protocols that did not elicit muscle soreness 231 
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or deficits in muscle function in the populations they used. By contrast, the protocol used in 232 
this study elicited muscle damage as evidenced by a ~21% reduction in muscle function 233 
alongside a reduction of ~27% for perceived muscle function measured using the LEFS and a 234 
17-fold increase in perceived soreness at 48 hr post-protocol (see Tables 4 and 5), at which the 235 
negative effects of muscle damage are known to peak (Cheung, Hume, & Maxwell, 2003). 236 
Furthermore, this study targeted the hamstring muscle group as the location for inducing 237 
muscle damage when previous studies targeted the quadriceps (de Carvalho et al., 2019; 238 
Morgan et al., 2018; Peschek et al., 2013). The knee flexors are ostensibly more susceptible to 239 
muscle damage than the knee extensors following eccentric exercise (Chen, Lin, Chen, Lin, & 240 
Nosaka, 2011). Thus, it may be more pertinent to investigate the hamstrings and recovery, 241 
espcially when considering the high injury rate of the knee flexors in sport, e.g., soccer 242 
(Ekstrand et al., 2011). These methodological differences make comparisons difficult to make 243 
between this current study and the previous literature. 244 
The reductions in peak torque in the present research that were observed in the days post-EIMD 245 
are likely due to a combination of the mechanical disruptions and subsequent oxidative stress 246 
elicited by the exercise protocol. The high levels of oxidative stress typically observed 247 
following EIMD, including similar protocols to the one utilised in the current study (Nikolaidis 248 
et al., 2007), can cause the muscle to enter an oxidised state, limiting contractile capability 249 
(Powers & Jackson, 2008). However, although CF have been shown to blunt exercise-induced 250 
oxidative stress (Davison et al., 2012), the high variability between individuals in regard to the 251 
level of oxidative stress seen in response to exercise must be considered when interpreting 252 
these findings (Mullins et al., 2013). Additionally, it is unlikely that CF outcompete the existing 253 
antioxidant defence system. Instead, epicatechin and catechin metabolites may upregulate the 254 
endogenous antioxidant enzymes rather than act directly on ROS (Ruijters, Weseler, Kicken, 255 
Haenen, & Bast). Nonetheless, such effects require confirmation with future research. 256 
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Therefore, with the previous in mind, and as no markers of oxidative stress were taken, it is 257 
difficult to conclude that the large effect sizes seen between CF1245 and CON for MVIC60%, 258 
MVIC30 and MVIC30% at 24 and 48 hr post-EIMD (d≥0.8) are a result of CF reducing 259 
oxidative damage. Hence, more research is required to understand the potential benefits of CF 260 
as a recovery aid. 261 
For subjective measures of muscle soreness it was hypothesised that CF consumption may 262 
reduce muscular soreness via the inhibition of pro-inflammatory cytokines, which are 263 
associated with neuropathic pain (Zhang & An, 2007). This was not the case in the present 264 
study, as subjective measures did not differ between groups. However, a large effect size was 265 
observed between CF1245 and CON for VAS at 48 hr post-EIMD (difference of 31 mm, d=0.9). 266 
The inflammatory process begins immediately following muscle damaging exercise, further 267 
developing in the subsequent 24-48 hr if the disruption is significant (Saxton, Claxton, Winter, 268 
& Pockley, 2003). As the peak rate of absorption for CF is ~30 min post-ingestion, it is feasible 269 
that the acute dose of 1245mg CF could reduce the immediate increase in cytokines and other 270 
inflammatory mediators (e.g., neutrophils) that propagate following exercise. Because these 271 
mediators have the capacity to exacerbate muscle damage (Paulsen et al., 2012; Pizza, Peterson, 272 
Baas, & Koh, 2005; Toumi & Best, 2003) and delay recovery in the subsequent days, an early 273 
reduction in this response could lead to an enhanced recovery. This effect may result from the 274 
inhibitory potential of CF monomers on tumour necrosis factor-α, a pro-inflammatory cytokine 275 
involved in muscle lysis (Liao, Zhou, Ji, & Zhang, 2010; Mao, van de Water, Keen, Schmitz, 276 
& Gershwin, 2002). Nonetheless, these are speculative mechanisms that require confirmation 277 
from further research that includes a comprehensive array of inflammation mediators. Our 278 
inability to measure these in the present study is acknowledged as a limitation of the work. 279 
This study is not without its limitations, firstly, even though menstrual cycle was accounted for 280 
through the use of self-report questionnaires; they are not as accurate as hormonal tests to 281 
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appropriately determine cycle phase (Wideman, Montgomery, Levine, Beynnon, & Shultz, 282 
2013). However, hormone analysis was not feasible for the current research. Secondly, it is 283 
possible that the interindividual variability associated with muscle damage (Damas, Nosaka, 284 
Libardi, Chen, & Ugrinowitsch, 2016) and variability between sex responses to EIMD 285 
(Sewright, Hubal, Kearns, Holbrook, & Clarkson, 2008) reduced the power of this study when 286 
paired with relatively small groups. Thirdly, no inflammatory or oxidative stress markers were 287 
taken, thus it was not possible to ascertain whether the intervention did in fact reduce these 288 
markers. Future research should look to include these measures and investigate the effect of 289 
CF supplementation on repeated bouts of high-intensity exercise seperated by short recovery 290 
times to better reflect competition patterns typical of team-sport athletes. 291 
In conclusion, there is no significant benefit for muscle recovery when comparing an acute 292 
dose of either 830 and 1245 mg CF to a nutrient matched carbohydrate-protein control. 293 
However, this needs to be confirmed with future research, whilst addressing the limitations 294 
above, to confirm or refute any benefits CF supplementation may have following a dose >1000 295 
mg. Research should focus on CF impact on repeat performance and a more comprehensive 296 
study investigating sex differences following CF supplementation should be conducted. 297 
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Tables 444 
Table 1. Participant characteristics  
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Group Age ± years Stature ± cm Mass ± kg 
CON 24 ± 4 175 ± 8 74 ± 15 
CF830 25 ± 5 168 ± 9 68 ± 10 
CF1245 24 ± 5 168 ± 11 65 ± 12 
Note: Data is presented as mean ± standard deviation. No significant differences observed 
between groups.  
 445 
 446 
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Table 2. Nutritional information of beverages  
 kcal/kj CHO (g) Pro (g) Fat (g) Flavanol (mg) ORAC 
CON 340/1427 61.9 19 1.9 Nil Nil 
CF830 366/1531 63.3 21.4 2.9 830 20,000 
CF1245 379/1589 64 22.6 3.4 1245 30,000 
Note: All drinks contain 60 g of maltodextrin and 25 g chocolate smooth whey protein powder, drinks 
2 & 3 contain 10 g and 15 g of Chococru powder respectively; ORAC = oxygen radical absorbance 
capacity. 
 448 
 449 
 450 
 451 
 452 
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Table 3. Dietary intake between groups 
 CON CF830 CF1245 Significance (P) 
Energy (kcal) 2137 ± 559 2101 ± 394 2164 ± 591 0.98 
Protein (g) 109 ± 49 106 ± 47 106 ± 43 0.99 
CHO (g) 227 ± 46 253 ± 41 265 ± 106 0.60 
Fat (g) 93 ± 32 81 ± 19 79 ± 21 0.57 
Note: Group mean ± SD 
Table 4. Changes in MVIC following EIMD 
  Time post-EIMD (hr) 
Measure Group Baseline 0 24 48 72 
MVIC 60 (Nm) 
CON 92 ± 23  79 ± 24 71 ± 18 62 ± 21 69 ± 22  
CF830 95 ± 30  87 ± 26 83 ± 30 77 ± 31 86 ± 34 
CF1245 94 ± 42  74 ± 30 87 ± 37 77 ± 30 79 ± 33 
MVIC 30 (Nm) 
CON 97 ± 29  88 ± 28 82 ± 21 68 ± 17 81 ± 26 
CF830 102 ± 35  99 ± 36 93 ± 34 89 ± 33 98 ± 40 
 CF1245 104 ± 44 87 ± 33 91 ± 34 86 ± 28 91 ± 31 
20 
 
Notes: Group mean ± SD 
 
 
 
Table 5. Changes in perceived soreness post-EIMD 
  Time post-EIMD (hr) 
Measure Group Baseline 0 24 48 72 
VAS (mm) 
CON 5 ± 8 76 ± 46 96 ± 42 131 ± 28 74 ± 28 
CF830 10 ± 13 45 ± 32 79 ± 26 124 ± 28 95 ± 34 
CF1245 6 ± 9 72 ± 40 72 ± 38 100 ± 44 83 ± 57 
LEFS (a.u.) 
CON 79 ± 1 67 ± 12 63 ± 15 55 ± 14 66 ± 6 
CF830 77 ± 2 72 ± 3 66 ± 8 54 ± 10 63 ± 8 
CF1245 77 ± 4 65 ± 10 67 ± 10 62 ± 12 68 ± 7 
Notes: Group mean ± SD 
453 
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Figures 454 
 455 
 456 
Figure 1. Study schematic detailing experimental timeline 457 
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 458 
Figure 2. Percentage change from baseline for MVIC following EIMD 459 
 460 
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